Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Inflammatory Back Conditions Conditions characterized primarily by inflammation, including facet joint irritation and early-stage disc degeneration, represent good candidates for BPC-157 therapy
Key Features Sterile, non-pyrogenic diluent for injection Contains 0.9% benzyl alcohol preservative Multi-dose vial for repeated use 30 mL volume Designed for dilution or reconstitution of injectable medications Suitable for professional medical use Common Uses Reconstituting medications Diluting injectable drugs Clinical and healthcare facility applications **Note Sterile and latex free Store between 20 and 25 degree
The treatment is a relatively painless procedure that does not require any numbing agent
After 4 weeks at therapeutic doses, most users report 50-70% reduction in pain, significantly improved function, and ability to resume modified training or activities
US$ 25.80
US$ 24.31
US$ 22.34
US$ 22.76
US$ 29.77
